Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

Author:

Vojdeman Fie J.12,Herman Sarah E. M.3,Kirkby Nikolai4,Wiestner Adrian3,van t’ Veer Mars B.5,Tjønnfjord Geir E.6,Itälä-Remes Maija A.7,Kimby Eva8,Farooqui Mohammed Z.3,Polliack Aaron9,Wu Ka Lung10,Doorduijn Jeanette K.11,Alemayehu Wendimagegn G.12,Wittebol Shulamiet13,Kozak Tomas14,Walewski Jan15,Abrahamse-Testroote Martine C. J.12,van Oers Marinus H. J.16,Geisler Christian H.1,Niemann Carsten U.1

Affiliation:

1. Department of Hematology, Rigshospitalet, Copenhagen, Denmark;

2. Department of Clinical Biochemistry, Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark;

3. Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA;

4. Department of Microbiology, Rigshospitalet, Copenhagen, Denmark;

5. Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands;

6. Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway;

7. Department of Hematology, Turku Central University Hospital, Turku, Finland;

8. Division of Hematology, Department of Medicine at Huddinge, Karolinska Institute, Stockholm, Sweden;

9. Department of Hematology, Hadassah University Hospital, Hebrew University Medical School, Jerusalem, Israel;

10. Department of Hematology, Stuivenberg Hospital, Antwerpen, Belgium;

11. Department of Hematology, Erasmus MC Cancer Center, Rotterdam, The Netherlands;

12. HOVON Data Centre, Erasmus MC, Rotterdam, The Netherlands;

13. Department of Internal Medicine, Gelderse Vallei Hospital, Amersfoort, The Netherlands;

14. Department of Clinical Hematology, Third Faculty of Medicine, Charles University Hospital Kralovske Vinohrady, Prague, Czech Republic;

15. Lymphoid Malignancies, Maria Sklodowska – Curie Memorial Institute and Oncology Centre, Warszawa, Poland;

16. Department of Hematology, Academisch Medisch Centrum, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3